In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation
Krupar, Rosemarie, Watermann, Christian, Idel, Christian, Ribbat-Idel, Julika, Offermann, Anne, Pasternack, Helen, Kirfel, Jutta, Sikora, Andrew G., Perner, SvenVolume:
10
Journal:
Scientific Reports
DOI:
10.1038/s41598-020-66329-7
Date:
December, 2020
File:
PDF, 5.89 MB
2020